1.82 (4.83%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Sionna Therapeutics, Inc.
Telephone
1.617.819.2020
Address
Suite 500, 21 Hickory Drive, Waltham, MA 02451
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 12.42 - 48.44
Trade Value (12mth)
US$2,471,957.00
1 week
-6.32%
1 month
-9.83%
YTD
-3.9%
1 year
179.11%
All time high
48.44
EPS 3 yr Growth
84.50%
EBITDA Margin
0.00%
Operating Cashflow
-$66m
Free Cash Flow Return
-27.10%
ROIC
-30.70%
Interest Coverage
0.00
Quick Ratio
20.60
Shares Outstanding (Fully Diluted)
45m
HALO Sector
Healthcare
Next Company Report Date
25-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 12 May 26 | |
| 12 May 26 | |
| 12 May 26 | |
| 02 March 26 | |
| 02 March 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -1.07 | -1.4 | -1.68 | | | | ||
EPS (Fully Diluted) | $ | | | | | -1.07 | -1.4 | -1.68 | | | | ||
Growth | % | | | | | -17.4 | -30.5 | -20.4 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
